Clinical Trials Sponsored by PSA Automobiles S.A.

Total 1354 results

Rhizen Pharmaceuticals SA

Completed

Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic, B-Cell

Georgia, Bulgaria, Poland
Med Discovery SA

Completed

PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers

Prostatic Neoplasms

Switzerland
Biosensors Europe SA

Active, not recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Acute Coronary Syndrome | High Bleeding Risk

United States, Canada, France, Italy, United Kingdom, Germany, Denmark
Naturex SA
BioFortis

Completed

A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects (TURBIO-GOLD)

Liver Function | Gastrointestinal Tolerance | Kidney Function

France
MedDay Pharmaceuticals SA

Terminated

Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) (SPI2)

Multiple Sclerosis

United States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
Medacta International SA

Completed

Pedicle Screw Positioning With MySpine vs Free Hand Technique

Spinal Deformity
AB Biotics, SA

Completed

Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota

Vaginal Infection

Spain
Biosensors Europe SA

Completed

BioFreedom Pharmacokinetic Study

Myocardial Infarction | Coronary Artery Disease

Spain
Chiesi SA/NV

Unknown

Adherence Evaluation in COPD

COPD | Adherence, Treatment

Belgium
Medacta International SA

Completed

Matched Pair Study - Kinematic vs Mechanical Alignment

Osteoarthritis, Knee | Joint Disease

Germany
Bio Sidus SA

Completed

Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers

Anemia
Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL

Classical Hodgkin Lymphoma

United States
Rhizen Pharmaceuticals SA

Terminated

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

Lymphoma

United States, Australia
Regen Lab SA

Completed

Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT

Keloid
Regen Lab SA

Unknown

Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

Knee Osteoarthritis

France
Debiopharm International SA

Completed

Study of Debio 1450 for Bacterial Skin Infections

Bacterial Infections

United States
Celyad Oncology SA

Withdrawn

EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 (EPITHINK)

Myelodysplastic Syndromes | AML, Adult
Biosensors Europe SA

Completed

e-BioMatrix Canada Registry

Device Related MACE and Bleeding

Canada
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Registry (eBMX-PMR)

Coronary Artery Disease

United Kingdom, Spain, France, Ireland, Switzerland, Germany, Denmark, Austria, Latvia, Czechia, Jordan, Lithuania, Morocco, Poland, Portugal, Russian Federation
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Surveillance Registry

Coronary Artery Disease

Switzerland, Spain, United Kingdom
Miracor Medical SA

Completed

PiCSO in ACS Study

Acute Coronary Syndrome

United Kingdom
Medacta International SA

Unknown

Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy

Arthroplasty | Replacement, Knee

Switzerland
Helsinn Healthcare SA

Terminated

Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients

Breast Cancer | Lung Cancer | Colon Cancer

Italy
Rhizen Pharmaceuticals SA

Completed

To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

Healthy

Canada
MedDay Pharmaceuticals SA

Completed

MD1003-AMN MD1003 in Adrenomyeloneuropathy

Adrenoleukodystrophy | Adrenomyeloneuropathy | AMN

France, Germany, Spain
Helsinn Healthcare SA

Completed

Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA (MEI-005)

Myelodysplastic Syndrome | MDS

United States
Debiopharm International SA

Terminated

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Hepatitis C

United States
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Helsinn Healthcare SA

Withdrawn

Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer

Cancer Patients With Cachexia

Australia
Debiopharm International SA

Completed

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Chronic Pain | Hepatitis C

United States, Belgium, Germany, Taiwan, Australia, France, Thailand, Puerto Rico, United Kingdom, Italy, India, Poland, Korea, Republic of, Canada
Celyad Oncology SA

Unknown

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL (CHART-2)

Heart Failure
Debiopharm International SA

Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Hepatitis C | Liver Disease

Germany, Sweden, United Kingdom, Poland
Rheon Medical SA

Unknown

Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device

Glaucoma

Switzerland
Debiopharm International SA

Completed

A Single Dose Study of Debio 1450 in Healthy Subjects

Bacterial Infections

United States
Air Liquide SA

Terminated

General Anesthesia With Xenon in Inspiratory Concentrations of 50% and 70% and Total I.V. Anaesthesia.

Anaesthesia

United Kingdom, France, Germany
Miracor Medical SA

Completed

PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention (pRAMSES)

ST Elevation (STEMI) Myocardial Infarction

Netherlands
Helsinn Healthcare SA

Completed

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

Diarrhea

Russian Federation, Bulgaria, Hungary, Romania
Cerenis Therapeutics, SA

Completed

Exploratory Study of Plaque Regression (EXPRESS)

Heterozygous Familial Hypercholesterolemia

Canada
Air Liquide SA

Completed

NOWOX Oxygen Therapy Monitoring Device

Chronic Obstructive Pulmonary Disease

France
Fovea Pharmaceuticals SA

Completed

Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Fovea Pharmaceuticals SA

Terminated

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion (FOV2302)

Central Retinal Vein Occlusion | Macular Edema

France
SeneXta Therapeutics SA

Completed

Safety and Pharmacokinetics of SNX-001 in Healthy Aged Volunteers

Safety

Germany
Future Biome SA

Recruiting

Fungal Fiber for Gut Health (FUN4GUT)

Immune Response | Stress | Nutrition, Healthy | Gut Microbiome | Low-grade Chronic Inflammation | Activity of Daily Living | Gut Health | Mild Gastrointestinal Symptoms in Healthy Adults | Gut Permeability

Argentina
Technophage, SA
VectorB2B

Not yet recruiting

Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia (RECOVER)

Pneumonia, Ventilator-Associated

France
Ryvu Therapeutics SA

Recruiting

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML (RIVER-52)

Acute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome

Poland
Medacta International SA

Recruiting

Interference Screw Mectascrew-B Postmarket Study

Anterior Cruciate Ligament Injuries Posterior Cruciate Ligament Tear

Germany
Debiopharm International SA

Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty (LIBELULA)

Central Precocious Puberty

United States
Novostia SA
Veranex

Recruiting

PILot Aortic Triflo Valve Study (PILATUS)

Aortic Valve Disease

Lithuania
Medacta International SA

Recruiting

Clinical and Radiological Outcomes of Medacta Shoulder System FR

Avascular Necrosis | Fracture | Primary Osteoarthritis | Secondary Osteoarthritis | Rotator Cuff Tear Arthropathy | Rheumatoid Arthritis Shoulder | Revision of Shoulder Arthroplasty

France
Medacta International SA

Recruiting

Multicenter Mpact DM France

Total Hip Arthroplasty | Survival, Prosthesis

France

Clinical Trials Sponsored by PSA Automobiles S.A.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations